{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:56:17Z","timestamp":1790571377642,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is the second leading cause of cancer-related death in men worldwide, with metastasis and drug resistance representing major drivers of mortality. Transient receptor potential mucolipin 1 (TRPML1), a member of the transient receptor potential channel superfamily, is associated with several malignancies; however, its role in PCa remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>TRPML1 expression in PCa is analyzed using public datasets from The Cancer Genome Atlas, Human Protein Atlas, and Cancer Cell Line Encyclopedia. Functional studies are performed in prostate cancer cell lines, particularly LNCaP and 22Rv1, using the TRPML1 inhibitor ML-SI1 and TRPML1-knockout models. Cell proliferation, cell cycle distribution, migration, and invasion are assessed using colorimetric cell viability assays, flow cytometry, and Transwell assays. Transcriptomic analysis, quantitative real-time PCR, western blotting, and spermine measurement are performed to investigate the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TRPML1 expression is elevated in PCa tissues compared to adjacent normal tissues. In LNCaP cells, ML-SI1 reduces cell viability and migration and induces G0\/G1-phase arrest, whereas in 22Rv1 cells, it exerts limited effects on cell viability and cell-cycle distribution but reduces migration and invasion. ML-SI1 reduces androgen receptor (AR) protein stability and spermine levels in LNCaP cells, whereas increased spermine levels are observed in 22Rv1 cells at 24\u2005h.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      , TRPML1 inhibition produces distinct cellular responses in LNCaP and 22Rv1 cells and is accompanied by differential changes in AR regulation and polyamine metabolism. Further mechanistic and\n                      <jats:italic>in vivo<\/jats:italic>\n                      studies are required to determine the biological and therapeutic relevance of these findings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1959805","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:15Z","timestamp":1790569755000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiongzheng","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jipeng","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Medical Genetics, College of Basic Medical Sciences, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Medical Genetics, College of Basic Medical Sciences, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Histology and Embryology, College of Basic Medical Sciences, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Basic Medical Sciences, The Medical Basic Research Innovation Center of Airway Disease in North China, Key Laboratory of Pathobiology, Ministry of Education, Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.32074\/1591-951X-822","article-title":"Prostate pathology: what is new in the 2022 WHO classification of urinary and male genital tumors?","volume":"115","author":"Surintrspanont","year":"2023","journal-title":"Pathologica"},{"key":"B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity \u2014 United States, 2001\u20132017","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/his.14707","article-title":"Neuroendocrine differentiation in the setting of prostatic carcinoma: contemporary assessment of a consecutive series","volume":"81","author":"Gopalan","year":"2022","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/PAP.0000000000000303","article-title":"Intraductal carcinoma of the prostate: a guide for the practicing pathologist","volume":"28","author":"Varma","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2022.09.010","article-title":"Genomic characterization of prostatic basal cell carcinoma","volume":"193","author":"Low","year":"2023","journal-title":"Am J Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature02196","article-title":"TRP channels as cellular sensors","volume":"426","author":"Clapham","year":"2003","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/15548627.2023.2300922","article-title":"MCOLN\/TRPML channels in the regulation of MTORC1 and autophagy","volume":"20","author":"Huang","year":"2024","journal-title":"Autophagy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107713","DOI":"10.1016\/j.pharmthera.2020.107713","article-title":"Two-pore and TRPML cation channels: regulators of phagocytosis, autophagy and lysosomal exocytosis","volume":"220","author":"Rosato","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/biomedicines12040865","article-title":"Metabolomic approach to identify potential biomarkers in KRAS-mutant pancreatic cancer cells","volume":"12","author":"Kim","year":"2024","journal-title":"Biomedicines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41420-024-02026-y","article-title":"Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis","volume":"10","author":"Fan","year":"2024","journal-title":"Cell Death Discov"},{"key":"B13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/cells13020115","article-title":"Modulation of cisplatin sensitivity through TRPML1-mediated lysosomal exocytosis in ovarian cancer cells: a comprehensive metabolomic approach","volume":"13","author":"Kim","year":"2024","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ceca.2019.02.010","article-title":"The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways","volume":"79","author":"Xu","year":"2019","journal-title":"Cell Calcium"},{"key":"B15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ncb3324","article-title":"A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation","volume":"18","author":"Li","year":"2016","journal-title":"Nat Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1038\/s41467-019-13572-w","article-title":"TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKK\u03b2\/VPS34 pathway","volume":"10","author":"Scotto Rosato","year":"2019","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"109848","DOI":"10.1016\/j.celrep.2021.109848","article-title":"Lysosomal Zn2+release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma","volume":"37","author":"Du","year":"2021","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e202403104","DOI":"10.1083\/jcb.202403104","article-title":"Activation of lysosomal Ca2+channels mitigates mitochondrial damage and oxidative stress","volume":"224","author":"Feng","year":"2025","journal-title":"J Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"eaaz2736","DOI":"10.1126\/sciadv.aaz2736","article-title":"Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models","volume":"6","author":"Yu","year":"2020","journal-title":"Sci Adv"},{"key":"B20","doi-asserted-by":"publisher","first-page":"112966","DOI":"10.1016\/j.ejmech.2020.112966","article-title":"Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3","volume":"210","author":"Leser","year":"2021","journal-title":"Eur J Med Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2200085119","DOI":"10.1073\/pnas.2200085119","article-title":"The intracellular Ca2+ channel TRPML3 is a PI3P effector that regulates autophagosome biogenesis","volume":"119","author":"Kim","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"615568","DOI":"10.3389\/fonc.2021.615568","article-title":"Huaier extract inhibits prostate cancer growth via targeting AR\/AR-V7 pathway","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2021.06.020","article-title":"Metabolism and function of polyamines in cancer progression","volume":"519","author":"Novita Sari","year":"2021","journal-title":"Cancer Lett"},{"key":"B24","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41568-018-0050-3","article-title":"Polyamine metabolism and cancer: treatments, challenges and opportunities","volume":"18","author":"Casero","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15548627.2021.2008752","article-title":"Autophagy inhibition mediated by MCOLN1\/TRPML1 suppresses cancer metastasis via regulating a ROS-driven TP53\/p53 pathway","volume":"18","author":"Xing","year":"2022","journal-title":"Autophagy"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1326023","DOI":"10.3389\/fonc.2023.1326023","article-title":"Trpml1 as a potential therapeutic target for triple-negative breast cancer: a review","volume":"13","author":"Pan","year":"2023","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41571-018-0085-0","article-title":"Alternative splicing in prostate cancer","volume":"15","author":"Paschalis","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1080\/15548627.2021.1917132","article-title":"MCOLN1\/TRPML1 finely controls oncogenic autophagy in cancer by mediating zinc influx","volume":"17","author":"Qi","year":"2021","journal-title":"Autophagy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41568-022-00473-2","article-title":"Polyamines in cancer: integrating organismal metabolism and antitumour immunity","volume":"22","author":"Holbert","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1756-9966-30-95","article-title":"The mechanisms by which polyamines accelerate tumor spread","volume":"30","author":"Soda","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1210\/er.2011-0012","article-title":"Polyamines on the reproductive landscape","volume":"32","author":"Lef\u00e8vre","year":"2011","journal-title":"Endocr Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrc1454","article-title":"Polyamines and cancer: old molecules, new understanding","volume":"4","author":"Gerner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1352-8661(00)00082-X","article-title":"Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer","volume":"10","author":"Van Der Graaf","year":"2000","journal-title":"Magn Reson Mater Biol Phys Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.3390\/ijms22094382","article-title":"The emerging clinical role of spermine in prostate cancer","volume":"22","author":"Peng","year":"2021","journal-title":"IJMS"},{"key":"B35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12964-023-01373-0","article-title":"Polyamines: their significance for maintaining health and contributing to diseases","volume":"21","author":"Xuan","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nm1095-1040","article-title":"Identification of an endogenous inhibitor of prostatic carcinoma cell growth","volume":"1","author":"Smith","year":"1995","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"112798","DOI":"10.1016\/j.celrep.2023.112798","article-title":"Spermine is a natural suppressor of AR signaling in castration-resistant prostate cancer","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1959805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T04:29:16Z","timestamp":1790569756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1959805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1959805"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1959805","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1959805"}}